InnovAge
INNV
#5625
Rank
NZ$2.49 B
Marketcap
NZ$18.35
Share price
-1.54%
Change (1 day)
193.28%
Change (1 year)

Earnings for InnovAge (INNV)

Earnings in 2026 (TTM): -NZ$23.46 Million

According to InnovAge's latest financial reports the company's current earnings are NZ$0.94 Billion. In 2025 the company made an earning of NZ$8.63 Million, an increase over its 2024 earnings that were of -NZ$44.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for InnovAge from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$23.46 Million-371.68%
2025 NZ$8.63 M-119.56%
2024 -NZ$44.14 Million-24.58%
2023 -NZ$58.52 Million-31.82%
2022 -NZ$85.84 Million-681.94%
2021 NZ$14.74 M-388.91%
2020 -NZ$5.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Merck
MRK
NZ$22.22 B-96,784.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cocrystal Pharma
COCP
-NZ$15.27 Million-33.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.39 Million-24.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
NZ$0.86 B-3,867.87%๐Ÿ‡ฎ๐Ÿ‡ช Ireland